![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
TDF/FTC Pre-Exposure Prophylaxis (PrEP) from 2012 to 2018 in the OPERA Cohort
|
|
|
Reported by Jules Levin
10th IAS Conference on HIV Science, Mexico City, Mexico, 21-24 July 2019
Karam Mounzer1, Jennifer Fusco2, Ricky Hsu3,4, Laurence Brunet2, Vani Vannappagari5, Kevin Frost6, Mark Shaefer5, Alex Rinehart5, Keith Rawlings5, Evelyn Byrd Quinlivan7, Gregory Fusco2
1Philadelphia FIGHT, Philadelphia, PA, USA; 2Epividian, Durham, NC, USA; 3NYU Langone Medical Center, New York, NY, USA; 4AIDS Healthcare Foundation, New York, NY, USA; 5ViiV Healthcare, Research Triangle Park, NC, USA; 6AmFAR, New York, NY, USA;7AIDS Healthcare Foundation, Lithonia, GA, USA
![0816191](../images/081619/081619-5/0816191.gif)
![0816192](../images/081619/081619-5/0816192.gif)
![0816193](../images/081619/081619-5/0816193.gif)
![0816194](../images/081619/081619-5/0816194.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|